Quiz

Article

Clinical Quiz: Methotrexate for Pediatric Dermatoses

Author(s):

In recognition of the Pre-AAD 2024 meeting, take our quiz based on Society for Pediatric Dermatology resources.

Clinical Quiz: Methotrexate for Pediatric Dermatoses

Methotrexate has been a common treatment for a number of pediatric and adult dermatoses for more than 70 years. An immunosuppressant, there are a number of supporting reasons to incorporate methotrexate into dermatologic care—but there are also pediatric-specific risks and outcomes to be wary of, as well.

In recognition of the Society for Pediatric Dermatology (SPD) 2024 Pre-AAD Meeting in San Diego, CA, this year, this latest HCPLive Clinical Quiz tests readers’ knowledge on the SPD’s recommended management of methotrexate in pediatric patients with conditions including atopic dermatitis, psoriasis, alopecia areata and more. The 5-question quiz is based on recommendations from the SPD’s Patient Perspectives handout, originally published in Pediatric Dermatology in 2023.

How would you fare in treating young patients with acne? Take the quiz below!

What is the most common side effect of methotrexate in children, and how can it be prevented?


Reference

Lalor L, Todd P. Society for Pediatric Dermatology. Patient Perspectives: What is methotrexate and how does it work? Pediatric Dermatology: Vol. 40, No. 5 (2023). https://pedsderm.net/site/assets/files/1028/spd_methotrexate_color-1.pdf

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.